# The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers

> **NCT05083468** · PHASE1 · COMPLETED · sponsor: **Shanghai SIMR Biotechnology Co., Ltd.** · enrollment: 83 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SR750 tablet
- **DRUG:** matching placebo

## Key facts

- **NCT ID:** NCT05083468
- **Lead sponsor:** Shanghai SIMR Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-29
- **Primary completion:** 2022-10-14
- **Final completion:** 2022-10-14
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05083468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05083468, "The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05083468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*